secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001493152-24-023333
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Juvenescence exercises 377,865 warrants at $13.20 for $4.99M; remaining due Nov 2024 & June 2025
--------------------------------------------------------------------------------

- Juvenescence exercised 377,865 post-merger warrants at $13.20/share, generating $4,987,818 in proceeds.
- Upon exercise, Juvenescence also received incentive warrants for 377,865 shares at $18.00, expiring March 26, 2028.
- This exercise is one-third of total post-merger warrants; second third due by Nov 30, 2024, final third by June 30, 2025.
- Proceeds will be used for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224023333/0001493152-24-023333-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224023333/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023333

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer